483
Joel Schlessinger, M.D.FDA 483 - Joel Schlessinger, M.D. - December 12, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Joel Schlessinger, M.D., a clinical investigator in Omaha, NE, revealed a significant failure to report adverse effects. The firm did not document adverse events, which were deemed probably related to investigational products, in the electronic data capture system for multiple subjects. This indicates a serious lapse in clinical trial oversight and reporting.
Open in Dashboard
ID · 14e2e217-e113-41d4-b50f-e27162a6f26f